Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 135

1.

Infectious flexor hand tenosynovitis: State of knowledge. A study of 120 cases.

Mamane W, Lippmann S, Israel D, Ramdhian-Wihlm R, Temam M, Mas V, Pierrart J, Masmejean EH.

J Orthop. 2018 May 12;15(2):701-706. doi: 10.1016/j.jor.2018.05.030. eCollection 2018 Jun. Review.

PMID:
29881224
2.

Human mesenchymal stromal cell-derived extracellular vesicles attenuate aortic aneurysm formation and macrophage activation via microRNA-147.

Spinosa M, Lu G, Su G, Bontha SV, Gehrau R, Salmon MD, Smith JR, Weiss ML, Mas VR, Upchurch GR Jr, Sharma AK.

FASEB J. 2018 May 29:fj201701138RR. doi: 10.1096/fj.201701138RR. [Epub ahead of print]

PMID:
29812968
3.

Messengers of tolerance.

Bontha SV, Fernandez-Piñeros A, Maluf DG, Mas VR.

Hum Immunol. 2018 May;79(5):362-372. doi: 10.1016/j.humimm.2018.01.008. Epub 2018 Feb 2. Review.

PMID:
29402484
4.

Adenosine 2A Receptor Activation Attenuates Ischemia Reperfusion Injury During Extracorporeal Cardiopulmonary Resuscitation.

Mehaffey JH, Money D, Charles EJ, Schubert S, Piñeros AF, Wu D, Bontha SV, Hawkins R, Teman NR, Laubach VE, Mas VR, Tribble CG, Maluf DG, Sharma AK, Yang Z, Kron IL, Roeser ME.

Ann Surg. 2018 Jan 25. doi: 10.1097/SLA.0000000000002685. [Epub ahead of print]

PMID:
29373368
5.
6.

Chimeric Pneumoviridae fusion proteins as immunogens to induce cross-neutralizing antibody responses.

Olmedillas E, Cano O, Martínez I, Luque D, Terrón MC, McLellan JS, Melero JA, Más V.

EMBO Mol Med. 2018 Feb;10(2):175-187. doi: 10.15252/emmm.201708078.

7.

The Complexity of Antibody Responses Elicited against the Respiratory Syncytial Virus Glycoproteins in Hospitalized Children Younger than 2 Years.

Trento A, Rodríguez-Fernández R, González-Sánchez MI, González-Martínez F, Mas V, Vázquez M, Palomo C, Melero JA.

Front Microbiol. 2017 Nov 22;8:2301. doi: 10.3389/fmicb.2017.02301. eCollection 2017.

8.

Intragraft Molecular Pathways Associated with Tolerance Induction in Renal Transplantation.

Gallon L, Mathew JM, Bontha SV, Dumur CI, Dalal P, Nadimpalli L, Maluf DG, Shetty AA, Ildstad ST, Leventhal JR, Mas VR.

J Am Soc Nephrol. 2018 Feb;29(2):423-433. doi: 10.1681/ASN.2017030348. Epub 2017 Nov 30.

PMID:
29191961
9.

Corrigendum: Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state.

Rossey I, Gilman MSA, Kabeche SC, Sedeyn K, Wrapp D, Kanekiyo M, Chen M, Mas V, Spitaels J, Melero JA, Graham BS, Schepens B, McLellan JS, Saelens X.

Nat Commun. 2017 Nov 29;8:16165. doi: 10.1038/ncomms16165.

10.

Structure and immunogenicity of pre-fusion-stabilized human metapneumovirus F glycoprotein.

Battles MB, Más V, Olmedillas E, Cano O, Vázquez M, Rodríguez L, Melero JA, McLellan JS.

Nat Commun. 2017 Nov 16;8(1):1528. doi: 10.1038/s41467-017-01708-9.

11.

The outstanding questions in transplantation: It's about time….

Azzi J, Raimondi G, Mas V, Riella LV, Elfadawy N, Safa K, Wojciechowski D, Kanak M, Nog R, Maltzman JS, Ford ML, Pober JS, Luo XR, Rothstein D, Miller ML, Matthews D, Burlingham W, Levings M, Heeger P, Higdon L, Gill J, Gill RG, Alegre ML.

Am J Transplant. 2018 Jan;18(1):271-272. doi: 10.1111/ajt.14450. Epub 2017 Sep 2. No abstract available.

PMID:
28758364
12.

Effects of DNA Methylation on Progression to Interstitial Fibrosis and Tubular Atrophy in Renal Allograft Biopsies: A Multi-Omics Approach.

Bontha SV, Maluf DG, Archer KJ, Dumur CI, Dozmorov MG, King AL, Akalin E, Mueller TF, Gallon L, Mas VR.

Am J Transplant. 2017 Dec;17(12):3060-3075. doi: 10.1111/ajt.14372. Epub 2017 Jul 8.

PMID:
28556588
13.

Biomarker Guidelines for High-Dimensional Genomic Studies in Transplantation: Adding Method to the Madness.

Kurian SM, Whisenant T, Mas V, Heilman R, Abecassis M, Salomon DR, Moss A, Kaplan B.

Transplantation. 2017 Mar;101(3):457-463. doi: 10.1097/TP.0000000000001622. No abstract available.

PMID:
28212255
14.

Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state.

Rossey I, Gilman MS, Kabeche SC, Sedeyn K, Wrapp D, Kanekiyo M, Chen M, Mas V, Spitaels J, Melero JA, Graham BS, Schepens B, McLellan JS, Saelens X.

Nat Commun. 2017 Feb 13;8:14158. doi: 10.1038/ncomms14158. Erratum in: Nat Commun. 2017 Nov 29;8:16165.

15.

Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors.

Gilman MS, Castellanos CA, Chen M, Ngwuta JO, Goodwin E, Moin SM, Mas V, Melero JA, Wright PF, Graham BS, McLellan JS, Walker LM.

Sci Immunol. 2016 Dec 16;1(6). pii: eaaj1879. doi: 10.1126/sciimmunol.aaj1879. Epub 2016 Dec 9.

16.

Cellular and molecular profiling of graft injury post renal transplantation.

Mas VR, Maluf DG.

Curr Opin Organ Transplant. 2017 Feb;22(1):36-45. doi: 10.1097/MOT.0000000000000377. Review.

PMID:
27941467
17.

Structural, antigenic and immunogenic features of respiratory syncytial virus glycoproteins relevant for vaccine development.

Melero JA, Mas V, McLellan JS.

Vaccine. 2017 Jan 11;35(3):461-468. doi: 10.1016/j.vaccine.2016.09.045. Epub 2016 Sep 28. Review.

18.

Engineering, Structure and Immunogenicity of the Human Metapneumovirus F Protein in the Postfusion Conformation.

Más V, Rodriguez L, Olmedillas E, Cano O, Palomo C, Terrón MC, Luque D, Melero JA, McLellan JS.

PLoS Pathog. 2016 Sep 9;12(9):e1005859. doi: 10.1371/journal.ppat.1005859. eCollection 2016 Sep.

19.

Trivalency of a Nanobody Specific for the Human Respiratory Syncytial Virus Fusion Glycoprotein Drastically Enhances Virus Neutralization and Impacts Escape Mutant Selection.

Palomo C, Mas V, Detalle L, Depla E, Cano O, Vázquez M, Stortelers C, Melero JA.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6498-6509. doi: 10.1128/AAC.00842-16. Print 2016 Nov.

20.

Video-assisted functional assessment of index pollicisation in congenital anomalies.

Mas V, Ilharreborde B, Mallet C, Mazda K, Simon AL, Jehanno P.

J Child Orthop. 2016 Aug;10(4):301-6. doi: 10.1007/s11832-016-0756-2. Epub 2016 Jun 28.

21.

Systems Biology in Kidney Transplantation: The Application of Multi-Omics to a Complex Model.

Bontha SV, Maluf DG, Mueller TF, Mas VR.

Am J Transplant. 2017 Jan;17(1):11-21. doi: 10.1111/ajt.13881. Epub 2016 Jul 12. Review.

22.

Return to recreational sport and clinical outcomes with at least 2years follow-up after arthroscopic repair of rotator cuff tears.

Antoni M, Klouche S, Mas V, Ferrand M, Bauer T, Hardy P.

Orthop Traumatol Surg Res. 2016 Sep;102(5):563-7. doi: 10.1016/j.otsr.2016.02.015. Epub 2016 Apr 28.

23.

Influence of Respiratory Syncytial Virus F Glycoprotein Conformation on Induction of Protective Immune Responses.

Palomo C, Mas V, Thom M, Vázquez M, Cano O, Terrón MC, Luque D, Taylor G, Melero JA.

J Virol. 2016 May 12;90(11):5485-5498. doi: 10.1128/JVI.00338-16. Print 2016 Jun 1.

24.

Biomarkers of Transplant Tolerance: A Provisional Analysis for an Unmet Need.

Mas VR, Portilla D, Maluf DG.

Transplantation. 2016 Apr;100(4):705-6. doi: 10.1097/TP.0000000000001106. No abstract available.

PMID:
26950715
25.

Hidden Inflammatory Molecular Signatures in Graft Kidney Biopsies: Silent Markers of Graft Fate?

Maluf DG, Mueller TF, Mas VR.

Am J Transplant. 2016 Jul;16(7):1947-8. doi: 10.1111/ajt.13754. Epub 2016 Mar 15. No abstract available.

26.

The High-Risk Age Window After Pediatric Liver Transplantation: Modeling Allograft Loss Using Mathematical Tools.

Mas V, Archer KJ, Maluf D.

Transplantation. 2016 Mar;100(3):487-8. doi: 10.1097/TP.0000000000001010. No abstract available.

PMID:
26569068
27.

Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection.

Detalle L, Stohr T, Palomo C, Piedra PA, Gilbert BE, Mas V, Millar A, Power UF, Stortelers C, Allosery K, Melero JA, Depla E.

Antimicrob Agents Chemother. 2015 Oct 5;60(1):6-13. doi: 10.1128/AAC.01802-15. Print 2016 Jan.

28.

Epigenetics in Kidney Transplantation: Current Evidence, Predictions, and Future Research Directions.

Mas VR, Le TH, Maluf DG.

Transplantation. 2016 Jan;100(1):23-38. doi: 10.1097/TP.0000000000000878. Review.

PMID:
26356174
29.

Ischemia/reperfusion, does temperature matter? Laboratory perspective.

Mas VR.

Liver Transpl. 2015 Nov;21 Suppl 1:S1-5. doi: 10.1002/lt.24322. Review. No abstract available.

30.

Donor Hepatic Steatosis Induce Exacerbated Ischemia-Reperfusion Injury Through Activation of Innate Immune Response Molecular Pathways.

Gehrau RC, Mas VR, Dumur CI, Suh JL, Sharma AK, Cathro HP, Maluf DG.

Transplantation. 2015 Dec;99(12):2523-33. doi: 10.1097/TP.0000000000000857.

31.

Generation of monoclonal antibodies specific of the postfusion conformation of the Pneumovirinae fusion (F) protein.

Rodríguez L, Olmedillas E, Mas V, Vázquez M, Cano O, Terrón MC, Luque D, Palomo C, Melero JA.

J Virol Methods. 2015 Nov;224:1-8. doi: 10.1016/j.jviromet.2015.08.002. Epub 2015 Aug 12.

PMID:
26275682
32.

Ex Vivo Perfusion With Adenosine A2A Receptor Agonist Enhances Rehabilitation of Murine Donor Lungs After Circulatory Death.

Stone ML, Sharma AK, Mas VR, Gehrau RC, Mulloy DP, Zhao Y, Lau CL, Kron IL, Huerter ME, Laubach VE.

Transplantation. 2015 Dec;99(12):2494-503. doi: 10.1097/TP.0000000000000830.

33.

Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein.

Gilman MS, Moin SM, Mas V, Chen M, Patel NK, Kramer K, Zhu Q, Kabeche SC, Kumar A, Palomo C, Beaumont T, Baxa U, Ulbrandt ND, Melero JA, Graham BS, McLellan JS.

PLoS Pathog. 2015 Jul 10;11(7):e1005035. doi: 10.1371/journal.ppat.1005035. eCollection 2015 Jul.

34.

Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B Cells.

Traitanon O, Mathew JM, La Monica G, Xu L, Mas V, Gallon L.

PLoS One. 2015 Jun 18;10(6):e0129658. doi: 10.1371/journal.pone.0129658. eCollection 2015.

35.

Astrocyte Elevated Gene-1 (AEG-1) Contributes to Non-thyroidal Illness Syndrome (NTIS) Associated with Hepatocellular Carcinoma (HCC).

Srivastava J, Robertson CL, Gredler R, Siddiq A, Rajasekaran D, Akiel MA, Emdad L, Mas V, Mukhopadhyay ND, Fisher PB, Sarkar D.

J Biol Chem. 2015 Jun 19;290(25):15549-58. doi: 10.1074/jbc.M115.649707. Epub 2015 May 5.

36.

A step closer to individualization of hepatocellular carcinoma therapy.

Maluf DG, Mas VR.

J Vasc Interv Radiol. 2015 May;26(5):733-4. doi: 10.1016/j.jvir.2015.01.034. No abstract available.

PMID:
25921455
37.

Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells.

Gallon L, Traitanon O, Yu Y, Shi B, Leventhal JR, Miller J, Mas V, L X, Mathew JM.

Transplantation. 2015 Sep;99(9):1774-84. doi: 10.1097/TP.0000000000000717.

PMID:
25905982
38.

Reduced Renal Methylarginine Metabolism Protects against Progressive Kidney Damage.

Tomlinson JA, Caplin B, Boruc O, Bruce-Cobbold C, Cutillas P, Dormann D, Faull P, Grossman RC, Khadayate S, Mas VR, Nitsch DD, Wang Z, Norman JT, Wilcox CS, Wheeler DC, Leiper J.

J Am Soc Nephrol. 2015 Dec;26(12):3045-59. doi: 10.1681/ASN.2014030280. Epub 2015 Apr 8.

39.

The Pneumovirinae fusion (F) protein: A common target for vaccines and antivirals.

Melero JA, Mas V.

Virus Res. 2015 Nov 2;209:128-35. doi: 10.1016/j.virusres.2015.02.024. Epub 2015 Mar 1. Review.

PMID:
25738581
40.

Cellular and molecular immune profiles in renal transplant recipients after conversion from tacrolimus to sirolimus.

Gallon L, Traitanon O, Sustento-Reodica N, Leventhal J, Ansari MJ, Gehrau RC, Ariyamuthu V, De Serres SA, Alvarado A, Chhabra D, Mathew JM, Najafian N, Mas V.

Kidney Int. 2015 Apr;87(4):828-38. doi: 10.1038/ki.2014.350. Epub 2014 Oct 29.

41.

"20209C-T" a variant mutation of prothrombin gene mutation in a patient with recurrent pregnancy loss.

Prat M, Morales-Indiano C, Jimenez C, Mas V, Besses C, Checa MA, Carreras R.

Ann Clin Lab Sci. 2014 Summer;44(3):334-6.

PMID:
25117109
42.

A monomeric uncleaved respiratory syncytial virus F antigen retains prefusion-specific neutralizing epitopes.

Swanson KA, Balabanis K, Xie Y, Aggarwal Y, Palomo C, Mas V, Metrick C, Yang H, Shaw CA, Melero JA, Dormitzer PR, Carfi A.

J Virol. 2014 Oct;88(20):11802-10. doi: 10.1128/JVI.01225-14. Epub 2014 Jul 30.

43.

Polyclonal and monoclonal antibodies specific for the six-helix bundle of the human respiratory syncytial virus fusion glycoprotein as probes of the protein post-fusion conformation.

Palomo C, Mas V, Vázquez M, Cano O, Luque D, Terrón MC, Calder LJ, Melero JA.

Virology. 2014 Jul;460-461:119-27. doi: 10.1016/j.virol.2014.05.001. Epub 2014 May 29.

44.

Genetic inhibition of hepatic acetyl-CoA carboxylase activity increases liver fat and alters global protein acetylation.

Chow JD, Lawrence RT, Healy ME, Dominy JE, Liao JA, Breen DS, Byrne FL, Kenwood BM, Lackner C, Okutsu S, Mas VR, Caldwell SH, Tomsig JL, Cooney GJ, Puigserver PB, Turner N, James DE, Villén J, Hoehn KL.

Mol Metab. 2014 Mar 12;3(4):419-31. doi: 10.1016/j.molmet.2014.02.004. eCollection 2014 Jul.

45.

Evaluation of molecular profiles in calcineurin inhibitor toxicity post-kidney transplant: input to chronic allograft dysfunction.

Maluf DG, Dumur CI, Suh JL, Lee JK, Cathro EP, King AL, Gallon L, Brayman KL, Mas VR.

Am J Transplant. 2014 May;14(5):1152-1163. doi: 10.1111/ajt.12696. Epub 2014 Apr 2.

46.

Liver transplant complications in hepatitis C infected recipients: recurrence versus rejection.

Gehrau RC, Mas VR, Suh JL, Maluf DG.

Expert Rev Gastroenterol Hepatol. 2014 Jul;8(5):453-6. doi: 10.1586/17474124.2014.898562. Epub 2014 Mar 18.

PMID:
24641719
47.

Characterization of an enhanced antigenic change in the pandemic 2009 H1N1 influenza virus haemagglutinin.

García-Barreno B, Delgado T, Benito S, Casas I, Pozo F, Cuevas MT, Mas V, Trento A, Rodriguez-Frandsen A, Falcón A, Ortín J, Nieto A, Melero JA.

J Gen Virol. 2014 May;95(Pt 5):1033-42. doi: 10.1099/vir.0.061598-0. Epub 2014 Feb 14.

PMID:
24531414
48.

The urine microRNA profile may help monitor post-transplant renal graft function.

Maluf DG, Dumur CI, Suh JL, Scian MJ, King AL, Cathro H, Lee JK, Gehrau RC, Brayman KL, Gallon L, Mas VR.

Kidney Int. 2014 Feb;85(2):439-49. doi: 10.1038/ki.2013.338. Epub 2013 Sep 11.

49.

Impact of calcineurin-inhibitor conversion to mTOR inhibitor on renal allograft function in a prednisone-free regimen.

Chhabra D, Alvarado A, Dalal P, Leventhal J, Wang C, Sustento-Reodica N, Najafian N, Skaro A, Levitsky J, Mas V, Gallon L.

Am J Transplant. 2013 Nov;13(11):2902-11. doi: 10.1111/ajt.12437. Epub 2013 Sep 5.

50.

Regulation of molecular pathways in ischemia-reperfusion injury after liver transplantation.

Gehrau RC, Mas VR, Dumur CI, Ladie DE, Suh JL, Luebbert S, Maluf DG.

Transplantation. 2013 Nov 27;96(10):926-34. doi: 10.1097/TP.0b013e3182a20398.

Supplemental Content

Support Center